#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 25

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Thrombotic microangiopathy

Not recruiting

Registered drug

Study on Ravulizumab for Patients with Thrombotic Microangiopathy After Stem Cell Transplant

Registered drug

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Ravulizumab

Contact Research Centre

Acute graft versus host disease

Not recruiting

Investigational

Study on the Effectiveness and Safety of CYP-001 and Corticosteroids for Adults with High-Risk Acute Graft Versus Host Disease

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Allogeneic Mesenchymoangioblast-Derived Mesenchymal Stem Cells

Contact Research Centre

Hormone receptor positive breast cancer

Not recruiting

Registered drugNo placebo

Study of OP-1250 for Treating Advanced or Metastatic ER+, HER2- Breast Cancer in Patients After Endocrine and CDK4/6 Inhibitor Therapy

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Anastrozole

Contact Research Centre

Essential thrombocythaemia

Not recruiting

Registered drugNo placebo

Study on Bomedemstat for Patients with Essential Thrombocythemia Not Responding to or Intolerant of Hydroxyurea, Comparing with a Drug Combination

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Bomedemstat

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study Comparing Elranatamab and Lenalidomide for Patients with Newly Diagnosed Multiple Myeloma After Stem-Cell Transplantation

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Elranatamab

Contact Research Centre

Idiopathic pulmonary fibrosis

Not recruiting

InvestigationalNo placebo

Long-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Bi 1015550

Contact Research Centre

Dementia Alzheimer's type

Not recruiting

Investigational

Study on the Effects of AR1001 (Mirodenafil Dihydrochloride) for Patients with Early Alzheimer's Disease

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Mirodenafil Dihydrochloride

Contact Research Centre

Breast cancer+2

Not recruiting

Registered drug

Study of Tucatinib, Trastuzumab, and Pertuzumab for Patients with Advanced or Metastatic HER2+ Breast Cancer

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Pertuzumab

Contact Research Centre

Hidradenitis

Not recruiting

InvestigationalNo placebo

Study on the Long-Term Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide

Contact Research Centre

Plasma cell myeloma recurrent

Not recruiting

Registered drugNo placebo

Study Comparing Subcutaneous and Intravenous Isatuximab with Pomalidomide and Dexamethasone for Adults with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo

Italy

Participants:65+ years
Substances:Dexamethasone

Contact Research Centre

Anal cancer recurrent

Not recruiting

Registered drug

Study of Retifanlimab, Carboplatin, and Paclitaxel for Patients with Inoperable or Metastatic Anal Canal Squamous Cell Carcinoma Not Treated with Chemotherapy

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Axial spondyloarthritis

Not recruiting

Registered drug

Study of Secukinumab for Maintaining Remission in Patients with Non-Radiographic Axial Spondyloarthritis

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Secukinumab

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.